Clinical trial
Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With…
NCT00074204 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00074204 |
|---|---|
| Title | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
| Official title | A Phase III Study of Delayed vs. Immediate Second-Line Therapy With Docetaxel After Gemcitabine + Carboplatin in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel, gemcitabine hydrochloride |
| Enrollment | 17 |
| Start date | Oct 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Apr 1, 2008 |
| First posted | Dec 11, 2003 |
| Last update posted | Aug 16, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: